URINARY TRACT INFECTIONS IN WOMEN
Tanya M. Nazemi, MD
Eastside Urology Associates (Kirkland, WA)
Infections of the urinary tract are a common occurrence,
accounting for an estimated 7.3 million physician office visits annually.[i] In addition, approximately 30% of women will
have at least one symptomatic urinary tract infection (UTI) by the age of 24,
and almost half of all women will have at least one UTI in their lifetime.1,[ii]
Once a patient has had an infection of
the urinary tract, they are also likely to develop another infection in the
future.
Most UTIs are caused by bacterial organisms that originate
from the gastrointestinal tract and travel into the urinary tract via the
urethra. Certain bacteria tend to have more
virulent characteristics that allow them to adhere to host vaginal and
urothelial cells, thereby increasing the host’s risk for infection. In addition, some women have receptors on the
vaginal and urothelial cells that may cause them to be more susceptible to
infections.[iii] Infections of the urinary tract are most
commonly caused by E.coli, which
accounts for 85% of community-acquired and 50% of hospital-acquired
infections. Other bacteria including Proteus, Klebsiella, Enterococcus, and Staphylococcus are also common
pathogens.2
Various risk factors have been associated with UTIs in
women. Women who are sexually active
tend to have more frequent UTIs as intercourse can irritate the urethra and
allow for bacteria to more easily enter the urinary tract. Women who use diaphragms, spermicides, or
unlubricated condoms may also have higher risks of infection. In addition, any obstruction to the normal
flow of urine can increase the ability of bacteria to colonize and multiply
within the urinary tract. Obstruction
may occur from urethral strictures, stones in the bladder or urethra, urethral
diverticula, prolapse of the bladder or urethra, or foreign bodies. Women who have a compromised immune system
may be more susceptible to infections as they are unable to adequately mount a
defense against invading bacteria. This
may be seen in women with diabetes mellitus, chronic steroid use, women
undergoing chemotherapy, or women with AIDS.
Postmenopausal women are particularly susceptible to recurrent
UTIs. The loss of estrogen alters the
normal pH of the vagina which causes tissues to weaken and become
irritated. In addition to this, pH
changes cause loss of normal vaginal bacteria such as lactobacillus, which generally
limits the growth of pathogenic bacteria.[iv]
Women with UTIs may present with various signs and symptoms. Most will usually develop pain with urination,
urgency, frequency, strong odor to the urine, cloudy urine, or blood in the
urine (hematuria). In addition, some
women may develop incontinence, fevers, flank pain, or suprapubic pain. Flank pain, fever, chills, nausea, and
vomiting are signs of a more complicated infection of the kidneys, also known
as pyelonephritis, which often requires intravenous antibiotics and
hydration.
A presumptive diagnosis of UTI may be made with a urine
dipstick which can quickly assess for the presence of bacteria, white blood
cells, red blood cells, and nitrites (a bacterial breakdown product). Infection is later confirmed by culture of
the urine to appropriately identify the causative pathogen. If patients have recurrent culture-proven
infections with certain bacteria such as Proteus,
imaging studies such as CT or ultrasound may be used to rule out any anatomic abnormalities
or stones that may be acting as a nidus for the persistent infections. Similarly, patients with recurrent infections
and a history of hematuria may also be evaluated with imaging studies and cystoscopy,
in which a small scope is passed into the urinary tract to assess the bladder
and rule out any foreign bodies or other abnormalities.
Most uncomplicated urinary tract infections may be treated
with a short course of antibiotics. The
most commonly used antibiotics are filtered through the kidneys and concentrate
in the urine. These include penicillins
(Ampicillin), cephalosporins (Cephalexin), trimethoprim-sulfamethoxazole
(Bactrim), nitrofurantoin (Macrobid, Macrodantin, Furadantin), and quinolones
(Levofloxacin, Ciprofloxacin, Norfloxacin).
Other antimicrobials that may be used include aminoglycocides
(Gentamicin, Kanamycin) tetracylcines, and vancomycin, although these are less
common. The choice of which antibiotic
to use depends on the severity of the infection, patient comorbidities, renal
function, patient allergy, side effects, and bacterial pathogen. Generally, trimethoprim-sulfamethoxazole
(TMP-SMX) has been the most commonly used antibiotic for the treatment of
uncomplicated UTIs. It is inexpensive
and covers many urinary pathogens, although patients may develop skin irritation
and gastrointestinal upset. Nitrofurantoin
is also very effective against most common bacterial infections of the urinary
tract and generally has less GI side effects.
It is not as effective for more complicated infections or infections in
the kidney. However, bacterial resistance
to nitrofurantoin is low and the medication is generally well tolerated and
often used effectively for prophylaxis against recurrent infections. The quinolones are a group of broad spectrum
antibiotics that are highly effective in killing the majority of urinary
pathogens. Unfortunately, bacterial
resistance to quinolones as well as TMP-SMX has been rising due to
indiscriminate use of these medications.
The duration of therapy is generally 3-5 days but may be longer based on
the severity of the infection.
Women with UTIs may take steps to help prevent recurrent
infections. Simple measures include
drinking plenty of water, urinating frequently (which does not allow for bacteria
to colonize in the urinary tract), wiping from front to back, voiding
immediately following intercourse, and avoiding use of feminine hygiene sprays
and scented douches. Some studies have
found that drinking cranberry juice may have a protective effect against
recurrent UTIs as well.[v],[vi] For women who have repeated infections
associated with sexual intercourse, a course of continuous antibiotic
prophylaxis for 6-12 months or single dose antibiotics following intercourse
may reduce the rate of UTIs.[vii] For women who are postmenopausal, local estrogen
replacement with vaginal tablets, creams, or ring (Vagifem®, Estrace®,
Estring®) frequently restores the normal vaginal environment, allows
recolonization with lactobacilli, and decreases pathogenic bacterial
colonization, thus reducing UTIs.4,[viii]
UTIs are common and troublesome infections that affect
millions of women each year.
Preventative measures may be taken, however, early diagnosis and
initiation of appropriate antibiotic therapy is often effective.
[i] Foxman
B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection:
self-reported incidence and associated costs. Ann Epidemiol. 2000;10:509-515.
[ii] Wein,
A., Kavoussi, L., Novick, A. Partin, A, Peters, C. eds.: Campbell-Walsh
Urology, 9th ed: Elsevier, pp.221-301
[iii] Wright
KJ, Hultgren SJ. Sticky fibers and uropathogenesis: bacterial adhesins in the
urinary tract. Future Microbiol. 2006 Jun;1:75-87.
[iv] Kelley
C. Estrogen and its effect on vaginal atrophy in post-menopausal women. Urol
Nurs. 2007 Feb;27(1):40-5.
[v] Howell
AB. Bioactive compounds in cranberries and their role in prevention of urinary
tract infections. Mol Nutr Food Res. 2007 Jun;51(6):732-7.
[vi] Jepson
RG, Craig JC. A systematic review of the evidence for cranberries and
blueberries in UTI prevention. Mol Nutr Food Res. 2007 Jun;51(6):738-45.
[vii] Albert
X, Huertas I, Pereiro II, Sanfelix J, Gosalbes V, Perrota C. Antibiotics for
preventing recurrent urinary tract infection in non-pregnant women.Cochrane
Database Syst Rev. 2004;(3):CD001209.
[viii] Raz
R, Stamm WE: A controlled trial of intravaginal estriol in postmenopausal women
with recurrent urinary tract infections. N Engl J Med 1993;329:753-756.
|